IRCT2015101714333N43已完成未知
Effect of Allopurinol on progression of renal disease
Vice chancellor for research, Kermanshah University of Medical Sciences0 个研究点目标入组 180 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •informed consent of the patient;the diagnosis of renal glomerular filtration ;(GFR) of less than 60 and over 15; uric acid greater than 6 mg per dL; age over 18 years; no history of hospitalization during the past three months due to renal disease and no increase in creatinine number greater than 50% compared to the 3months ago.
- •Exclusion criteria: allopurinol intolerance;allergy; the possibility of pregnancy; liver disease history of gout
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Effect of Allopurinol on renal residual functioIRCT20090905002417N20Esfahan University of Medical Sciences98
招募中
3 期
Effect of allopurinol on diabetic nephropathyIRCT20200117046158N1Shahre-kord University of Medical Sciences60
已完成
不适用
Influence of febuxostat and allopurinol on renal function for hyperuricemiaHyperuricemic patients (Uric acid>8.0mg/dL)JPRN-UMIN000005964ihon University School of Medicine140
尚未招募
3 期
Evaluation of the effect of Allopurinol on the frequency of ventricular and supraventricular arrhythmiasCondition 1: Ventricular arrhythmias. Condition 2: Supraventricular arrhythmia.Re-entry ventricular arrhythmiaI47.0I47.1Supraventricular tachycardiaIRCT20120520009801N12Mashhad University of Medical Sciences134
进行中（未招募）
1 期
Estudio para valorar el efecto sobre las plaquetas del tratamiento con Alopurinol en pacientes diabéticosEUCTR2011-000619-16-ESFundación Investigación Biomedica. Hospital Clinico San Carlos